Treatment of BK Virus Infection With CTL Cells in Immunocompromised Transplant Patients

Summary

This is a pilot study using cytotoxic T lymphocytes (CTLs) manufactured with the Miltenyi CliniMACS Prodigy Gamma-capture system will be effective in decreasing specific viral load in patients with BK virus viremia and BK virus-associated symptoms post-allogeneic hematopoietic stem cell transplantation (HSCT), renal transplantation, and chemotherapy.

Timeline

Start

2019-10-07

Primary completion

2028-01-30

Completion

2029-01-30

Drugs

Indications